Important Current Status Update: As of March 19, 2025, the FDA has ended enforcement discretion for compounded tirzepatide
"We spent years working with our medical advisory board to formulate Lemme GLP-1 Daily into the most effective and researched GLP-1 supplement on the market
attorney in the Southern District of Florida
Haines noted that it is still unclear which patients are most likely to lose muscle and how this muscle loss might impact blood sugar control
Risks and Safety Considerations to Discuss With Your Doctor Key risks include cardiovascular effects from both agents, hormonal fluctuations due to rapid weight loss altering SHBG and free testosterone, gastrointestinal side effects, and the unknown combined safety profile of an unlicensed drug alongside a controlled hormone therapy
We wanted to make sure employers have the choice. Also on Thursday, the executive director of the Group Insurance Commission, the Massachusetts agency that provides health insurance for 460,000 state employees, said its been running a $20 million monthly deficit, partly due to rising claims from members taking GLP-1s to treat obesity